The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index; 11 of the 20 sources its claims cite were checked for support.
Utilization of a Meningitis/Encephalitis PCR panel at the University Hospital Basel – a retrospective study to develop a diagnostic decision rule
Open accessAbstract
Background: Meningitis/Encephalitis (ME) PCR panel covers 14 viral, bacterial, and fungal pathogens and has been implemented in many institutions worldwide. Post-marketing studies indicate a reduced sensitivity and overutilization underscoring the need for a more targeted usage. The aim of our study is to describe the utilization of the ME panel and to develop a diagnostic-stewardship based decision rule. Materials: Adult patients, who underwent CSF analysis with the ME panel between August 2016 and June 2021 at the University Hospital Basel, were included. Demographic, clinical, microbiological, and laboratory data were extracted from the electronic health record. Factors associated with a positive ME panel result were identified, and a decision rule was developed to potentially optimize the diagnostic yield and reduce the number of unnecessary tests. Results: (19%), Enterovirus (16%), Herpes simplex Virus 1/2 (16%), and Human Herpesvirus 6 (HHV-6, 13%). Fever, vomiting, headache, and photophobia were more frequently present in test positive patients as were significantly higher CSF leukocytes and protein concentrations. When simulating a decision rule based on CSF leukocytes and protein concentration, only 35% of all patients would have qualified for a ME panel tests, thereby increasing the positivity rate to 22.7%. 10 of 106 positive ME panels would have been missed, only involving HHV-6 and VZV (6 and 4 cases, respectively). As these subjects were either severely immunocompromised or had clinical features of shingles we propose extending the testing algorithm by including those criteria. Conclusion: The ME panel positivity rate at our institution was similar as previously published. Our results highlight the need for diagnostic-stewardship interventions when utilizing this assay by implementing a stepwise approach based on a limited number of clinical and laboratory features. This decision rule may improve the pretest probability of a positive test result, increase the quality of test utilization, and reduce costs.
Overview
CoChat Summary
## TL;DR
This retrospective single-center study found that the Biofire FilmArray ME PCR panel was used broadly at University Hospital Basel but had a positive rate of only 8.6% (106/1,236). The authors propose a decision rule based on CSF leukocytes and protein, which would have reduced testing to 35% of patients and increased the positivity rate to 22.7%, while missing 10 positive panels.
## Key findings
- Among 1,236 adult patients who received at least one ME panel, 106 were positive, for a positivity rate of 8.6% (95% CI 7.1–10.3%).
- The most frequent detected pathogens were VZV (29/106, 27.4%), Streptococcus pneumoniae (20/106, 18.9%), Enterovirus (17/106, 16%), HSV-1/2 (17/106, 16%), and HHV-6 (14/106, 13.2%).
- Fever, vomiting, headache, and photophobia were more common in test-positive patients, and CSF leukocytes and protein were significantly higher (p < 0.001).
- A rule using CSF leukocytes ≥10 × 10^6/L or CSF protein ≥1,000 mg/L would have qualified 423/1,194 patients (35%) for testing, raising the positivity rate to 96/423 (22.7%) and yielding a sensitivity of 90.6% (95% CI 83.3–95.4%) for detecting any pathogen.
- Under that rule, 10/106 positive results would have been missed; these were mainly HHV-6 (6 cases) and VZV (4 cases), and the authors note the missed cases were either immunosuppressed or had shingles-like clinical features.
## Methods
- Retrospective observational study at a single 700-bed teaching hospital in north-western Switzerland, including adult in- and outpatients (≥18 years) who underwent lumbar puncture with ME panel testing from August 2016 to June 2021.
- Data were extracted from electronic clinical and microbiological records, including demographic, clinical, microbiological, laboratory, and discharge-summary information; patients without sufficient records, with data refusal, or with repeated panels in the same admission/outpatient period were excluded.
- The analysis compared positive vs negative ME panels using chi-squared and Mann–Whitney U tests, then simulated a diagnostic decision rule based on limited clinical/laboratory features, especially CSF leukocytes and protein.
## Limitations
- The paper explicitly states limitations of retrospective, single-center design; absence of singleplex PCRs as a gold standard; unknown exact number of immunocompromised patients; lack of the proportion of patients with suspected CNS infection who underwent lumbar puncture; no analysis of lumbar puncture indications; keyword-based symptom extraction; and no validation cohort.
- Evident from the text: the proposed decision rule was only simulated on the same dataset and was not prospectively validated, so its real-world safety and performance remain unproven.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 1 Not valid · 2 Not checked · 31 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“This situation would be the only indication for modifying antiviral therapy (intravenous instead of oral) for VZV infection (31).”
§ Utilization of a Meningitis/Encephalitis PCR panel at the University Hospital Basel – a retrospective study to develop a diagnostic decision rule > Discussion
What the sources say
- Disputedcites [31] Dworkin, 2007, Recommendations for the management of herpes zoster, Clin Infect Dis sourceExperimental — accuracy not yet measured
The Neurologic complications of HZ section recommends intravenous acyclovir for meningitis and encephalitis, but also for myelitis. The Treatment of Immunocompromised Patients section recommends it for severely immunocompromised patients and transplant recipients with suspected visceral dissemination. Meningoencephalitis is therefore not the only indication given in the source; page numbers were not provided in our copy. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Every source the paper cites for this claim was checked and supports it.
In the paper
“According to Radmard et al. (11), who analyzed the ME panel accuracy, 10/13 positive results for HHV-6 were discordant or clinically irrelevant.”
§ Utilization of a Meningitis/Encephalitis PCR panel at the University Hospital Basel – a retrospective study to develop a diagnostic decision rule > Discussion
What the sources say
- Supportedcites [11] Radmard, 2019, Clinical utilization of the FilmArray meningitis/encephalitis (ME) multiplex polymerase chain reaction (PCR) assay, Front Neurol source
The Results (CSF ME Panel Results) explicitly report that 10 of 13 HHV-6-positive ME results were clinically discordant. The Methods (Sample Testing) define clinically discordant cases as those judged unlikely to represent infection, supporting the paraphrase “discordant or clinically irrelevant.” (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“These results are consistent with the assumption, that viral infections can lead to a modest change in cerebrospinal fluid parameters (18, 27)”
§ Utilization of a Meningitis/Encephalitis PCR panel at the University Hospital Basel – a retrospective study to develop a diagnostic decision rule > Discussion
What the sources say
- Supportedcites [18] Griffiths, 2018, Management of acute meningitis, Clin Med (Lond) source
Table 1 describes viral meningitis as having normal or mildly raised CSF opening pressure, mildly raised protein, and normal or slightly low glucose. These findings support the cited sentence's broad point that viral infection can produce modest changes in CSF parameters, though the table specifically concerns viral meningitis. (LLM, conf=0.87)
- Supportedcites [27] Benninger, 2017, CSF in acute and chronic infectious diseases, Handb Clin Neurol source
In the Introduction’s CSF analysis section (page not provided), the paper says CSF protein is usually mildly elevated in viral encephalitis and that CSF cell counts can be only borderline elevated or even normal early in illness. It also reports that glucose is usually normal in viral CNS infections. These findings support the claim that viral infections can produce modest changes in CSF parameters. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The ME panel positivity rate at our institution was similar as previously published.”
- Also stated in: § Discussion · plain
“Our results mirror previously reported data (11, 14) with a positivity rate of 8.6%.”
§ Utilization of a Meningitis/Encephalitis PCR panel at the University Hospital Basel – a retrospective study to develop a diagnostic decision rule > Abstract > Conclusion
What the sources say
- Supportedcites [11] Radmard, 2019, Clinical utilization of the FilmArray meningitis/encephalitis (ME) multiplex polymerase chain reaction (PCR) assay, Front Neurol source
The Results section (‘CSF ME Panel Results’; page not provided) reports 45 positive ME panel results among 705 inpatient samples, a published positivity rate of 6.4%. The cited paper supplies a prior rate for the citing authors’ comparison; it does not need to report the University Hospital Basel rate, which is the citing authors’ own finding. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [14] Broadhurst, 2020, Utilization, yield, and accuracy of the FilmArray meningitis/encephalitis panel with diagnostic stewardship and testing algorithm, J Clin Microbiol source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · plain
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“It was shown that shingles without neurological involvement may cause pleocytosis as well as VZV-DNA detection in CSF (29–31).”
§ Utilization of a Meningitis/Encephalitis PCR panel at the University Hospital Basel – a retrospective study to develop a diagnostic decision rule > Discussion
What the sources say
- Not checked — no full text of the sourcecites [29] Gold, 1966, Serologic and virus-isolation studies of patients with varicella or herpes-zoster infection, N Engl J Med source
- Not checked — no full text of the sourcecites [30] Appelbaum, 1962, Herpes zoster encephalitis, Am J Med source
- Supportedcites [31] Dworkin, 2007, Recommendations for the management of herpes zoster, Clin Infect Dis source
The Clinical Aspects of HZ section reports that immunocompetent patients without clinical CNS symptoms could have positive VZV PCR results in CSF, and that CSF leukocytosis occurred in 46% of patients. The Encephalitis section also states that CSF pleocytosis occurs in approximately 50% of people with uncomplicated shingles. The paper does not say that both findings occurred in every affected patient. (LLM, conf=0.92)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
20 more claims
Create a free account to see all 42 claims and every source verdict.
- It may state two separate claims as one. 14
- Probably not a substantial claim. 5
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Streptococcus pneumoniae was the most frequently detected bacterial pathogen, consistent with previous international studies,10,13,14,17,18 reinforcing its clinical importance despite vaccination programmes.”
From Utility and clinical relevance of multiplex PCR panels for diagnosis of central nervous system infections (2026) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The reduced time to obtain a diagnostic result has improved antimicrobial and antiviral treatment, enabling de-escalation of empiric therapy [3,6,8,9].”
From Performance Evaluation of Multiplex Molecular Syndromic Panel vs. Singleplex PCR for Diagnosis of Acute Central Nervous System Infections (2025) · cites this paper as [9]
Experimental — accuracy not yet measured
Citations
Cites
Recommendations for the management of herpes zoster
Dworkin, R. H., Johnson, R. W., Breuer, J., Gnann, J. W., Levin, M. J., Backonja, M., Betts, R. F., Gershon, A. A., Haanpää, M. L., McKendrick, M. W., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510206 · Cited by 869 · cited 2×
“This situation would be the only indication for modifying antiviral therapy (intravenous instead of oral) for VZV infection (31).”
BackgroundLeber, A. L., Everhart, K., Balada-Llasat, J.-M., Cullison, J., Daly, J., Holt, S., Lephart, P., Salimnia, H., Schreckenberger, P. C., DesJarlais, S., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00730-16 · Cited by 609 · cited 4×
“Although many institutions are already using it and several studies anticipate a benefit for clinical and antimicrobial stewardship outcomes (5, 10), the risk of overutilization as well as false-positive results reported in the literature, call for a more careful and evidence-based approach to this…”
BackgroundMethodInfluentialBurden of encephalitis-associated hospitalizations in the United States, 1998-2010
Vora, N. M., Holman, R. C., Mehal, J. M., Steiner, C. A., Blanton, J., & Sejvar, J. (2014) · Neurology · doi:10.1212/wnl.0000000000000086 · Cited by 264 · cited 1×
“It is estimated, that no pathogen is identified in approximately one-fourth to one-half of patients with acute meningoencephalitis, increasing the risk for therapy failure as well as morbidity (2, 3) and mortality.”
BackgroundTansarli, G. S., & Chapin, K. C. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.11.016 · Cited by 263
Acute encephalitis – diagnosis and management
Ellul, M., & Solomon, T. (2018) · Clinical Medicine · doi:10.7861/clinmedicine.18-2-155 · Cited by 244
Burden of encephalitis-associated hospitalizations in the United States, 1988-1997
Khetsuriani, N., Holman, R. C., & Anderson, L. J. (2002) · Clinical Infectious Diseases · doi:10.1086/341301 · Cited by 200 · cited 1×
“It is estimated, that no pathogen is identified in approximately one-fourth to one-half of patients with acute meningoencephalitis, increasing the risk for therapy failure as well as morbidity (2, 3) and mortality.”
BackgroundLiesman, R. M., Strasburg, A. P., Heitman, A. K., Theel, E. S., Patel, R., & Binnicker, M. J. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01927-17 · Cited by 186
Epidemiology of meningitis and encephalitis in the United States, 2011–2014
Hasbun, R., Rosenthal, N., Balada-Llasat, J. M., Chung, J., Duff, S., Bozzette, S., Zimmer, L., & Ginocchio, C. C. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix319 · Cited by 171
Serologic and virus-isolation studies of patients with varicella or herpes-zoster infection
Gold, E. (1966) · New England Journal of Medicine · doi:10.1056/nejm196601272740403 · Cited by 167
Guidelines on the management of infectious encephalitis in adults
Stahl, J. ‐., Azouvi, P., Bruneel, F., de Broucker, T., Duval, X., Fantin, B., Girard, N. J., Herrmann, J., Honnorat, J., Lecuit, M., et al. (2017) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2017.01.005 · Cited by 132
Cited by
Gabrielli, L., Tomaiuolo, M., Banchini, I., Balboni, A., Liberatore, A., Lanna, F., Cantiani, A., Bertoldi, A., Pavoni, M., Manzoli, L., et al. (2025) · Microorganisms · doi:10.3390/microorganisms13040892 · Cited by 5
Ryu, H., Sung, S., Park, K., Kim, M., Oh, Y., Yu, S., Cho, E., & Kim, S. (2025) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2025.106055 · Cited by 6
Berinson, B., Tanida, K., Spenke, L., Krivec, L., Keller, J., Rolvien, T., Christner, M., Lütgehetmann, M., Aepfelbacher, M., Klatte, T. O., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02239-24 · Cited by 7
“Here, the performance of costly analyses is linked to specific, objectifiable rule-in criteria, that is, CSF pleocytosis (32, 33).”
From guesswork to guidelines: advancing diagnostic stewardship in immunocompromised hosts
Kinsella, P. M., Thursky, K., Slavin, M. A., & Reynolds, G. K. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2025.2545504 · Cited by 2
Tebben, J., Wiebalck, B., & Schmidt, H. (2025) · Neurological Research and Practice · doi:10.1186/s42466-025-00398-9 · Cited by 2
“As a result of our study, we implemented the parameters in a similar way as other hospitals [15].”
Metadata
- Authors
- Erba, A., Franzeck, F. C., Hinic, V., Egli, A., & Osthoff, M.
- Affiliations
- University Hospital of Basel (CH)
- University of Zurich (CH)
- Corresponding author
- Osthoff, Michael
- Venue
- Frontiers in Medicine
- Publisher
- Frontiers Media SA
- Published
- 2024-04-17
- Volume
- 11
- Pages
- 1351903-1351903
- ISSN
- 2296-858X (ISSN-L)
- PMC
- PMC11061443
- OpenAlex
- W4394888059
- Cited by
- 15
- References
- 31
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 3
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Keywords
- diagnostic decision rules, diagnostic stewardship, cerebrospinal fluid analysis, CSF protein concentration, test utilization, unnecessary testing, herpes simplex virus, human herpesvirus 6, varicella-zoster virus, immunocompromised patients, herpes zoster, pretest probability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Utilization of a Meningitis/Encephalitis PCR panel at the University Hospital Basel – a retrospective study to develop a diagnostic decision rule. https://app.cochat.ai/papers/10.3389/fmed.2024.1351903
- The paper
- Erba, A., Franzeck, F. C., Hinic, V., Egli, A., & Osthoff, M. (2024). Utilization of a Meningitis/Encephalitis PCR panel at the University Hospital Basel – a retrospective study to develop a diagnostic decision rule. Frontiers in Medicine. https://doi.org/10.3389/fmed.2024.1351903
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
